Category: Sponsors

Future Farm Signs LOI with CEPG Consulting and Design Inc. to Create Elite New Cannabis Strains in St. John’s NFLD

March 22, 2018 – Vancouver, British Columbia – Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQX: FFRMF) is pleased to announce that it has signed a Letter of Intent (“LOI”) to acquire a 50% interest in and to enter into a definitive joint venture agreement with CEPG Consulting and Design Inc. (“CEPG”) of St John’s, Newfoundland. The joint venture is formed to begin operations for a cannabis and hemp breeding program under its previously announced joint venture with Rahan Meristem Ltd. (“Rahan”), a world renown global agro-biotechnology company incorporated in the State of Israel. The joint venture will operate out of both an existing building and 6,000 square feet of newly constructed laboratories. CEPG is a Canadian corporation wholly owned by Snellen Holdings (1994) Co. Ltd. (“SHC”), based in St John’s, Newfoundland. SHC has been developing controlled environment plant growth systems since 1981. SHC will transfer ownership of land and a building located in St. John’s, Newfoundland, as well as a 48-ft trailer and its contents. CEPG will apply for a dealer license from health Canada, which will enable research and development to begin on the growth of cannabis plants. Once licensed, the R&D facility will use state-of-the-art controlled environment equipment and techniques to create a research hub for the Rahan and Future Farm JV, which is expected to create valuable IP to be sold...

Read More

FinCanna Provides an Update on CTI’s Medical Cannabis Extraction Facility in Coachella, California and Receives OTC Listing

CTI’s Extraction Facility Quickly Advancing Towards Full Commercialization VANCOUVER, British Columbia, March 19, 2018 — FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (OTCQB:FNNZF) announces that it has received its listing on the OTCQB under the symbol “FNNZF” and provides the following update on the interim medical cannabis extraction facility (“Extraction Facility”) of Cultivation Technologies Inc (“CTI”), FinCanna’s first investment in California. As announced on January 15, 2018, CTI took over direct operations of its Extraction Facility operating at its site in Coachella, California and CTI has the rights to 100% of the production capacity. CTI is quickly advancing towards commercialization and ramping revenue at the Extraction Facility from which FinCanna is entitled to receive 50% of the profits. This Extraction Facility can currently process an estimated 6,000 pounds of biomass per month translating to approximately 3.7 million grams of raw oil per year. CTI has the ability to add an additional extraction machine and fractional distillation and winterization equipment. This would result in additional capacity to process 3,000 pounds of biomass per month and the ability to service third-party vaporizer, winterization and distillation customers at a scale of approximately 100,000 grams of finished product weekly. CTI’s Coachella Premium Brand CTI’s own brand, Coachella Premium, recently introduced a line of medical concentrates which are now available for sale to all California licensed dispensaries. CTI is currently expanding its product line to include...

Read More

Puration Cannabis Infused Beverage Operation Prioritized In Canadian Deal

DALLAS, TX / ACCESSWIRE / March 20, 2018 / Puration, Inc. (OTC PINK: PURA) today announced its patented cannabis extraction capacity and corresponding cannabis-infused beverage business has been pushed to the top priority in the previously announced deal in Canada that Puration is working on with North American Cannabis Holdings, Inc. (OTC PINK: USMJ). Together, USMJ and PURA have been developing an opportunity to acquire a grow operation in Canada in advance of the pending nationwide legalization of recreational marijuana expected this coming July. The comprehensive acquisition deal includes PURA establishing and extraction facility and cannabis-infused beverage operation. PURA now expects to close the extraction and beverage operation business in advance of the grow operation acquisition. The extraction and beverage business deal is anticipated to be finalized as early as by the end of this week. The comprehensive acquisition deal remains on track and a letter of intent on the USMJ acquisition of the grow operation remains imminent. For more information on Puration, visit http://www.aciconglomerated.com. Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts,...

Read More

Hydropothecary selects Shopify to power ecommerce services for medical and recreational cannabis markets

GATINEAU, Quebec, March 20, 2018 (GLOBE NEWSWIRE) — The Hydropothecary Corporation (TSX-V:THCX) (“Hydropothecary”) has reached an agreement with Shopify, one of the world’s most respected online commerce companies, to build its ecommerce platform for cannabis products. The bilingual website will serve Hydropothecary’s medical customers, provide information for discerning recreational consumers and support engagement with provincial and territorial cannabis retailers. “Shopify is a great fit for our business, providing an ideal way for customers to learn, browse and buy,” said CEO Sebastien St-Louis. “As we move into new markets, Shopify’s platform allows us to provide informed and engaging online experiences to new consumers, while giving us the flexibility to adapt to regulatory challenges and market variations from province to province.” Working closely with Hydropothecary’s industry-leading customer-care team, the new platform will improve the shopping experience for medical cannabis patients by streamlining the medical registration and ordering process. Additionally, Shopify’s expertise in providing, secure and flexible ecommerce websites will be invaluable in serving cannabis consumers across Canada. “We are excited to work with an industry leader like Hydropothecary to deliver another innovative ecommerce solution to the Canadian cannabis market. The Shopify platform will allow Hydropothecary to rapidly capitalize on the emerging opportunities in medical and recreational cannabis in a safe, secure, and reliable way,” said Loren Padelford, VP at Shopify. About Hydropothecary Corporation The Hydropothecary Corporation is an authorized licensed producer...

Read More

Emblem Corp. Issues President’s Letter to Shareholders

TORONTO, March 20, 2018 (GLOBE NEWSWIRE) — Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Corporation”) provides a Letter to its Shareholders as follows: Spring is upon us, and Emblem is ready to bloom. Having just completed my first quarter as your new President and CEO of Emblem Corp., I would like to start by thanking the many groups who have made this exciting evolution of our company possible. The incredible support of our shareholder base and the significant efforts of our world-class management team have allowed us to quickly pivot our approach. This strategy strengthens our current position as a leading medical cannabis company, while creating a brand-leading division launch within the burgeoning adult-use market, slated to begin in Q3 2018. With the two financing transactions Emblem successfully completed in the last 120 days our balance sheet is incredibly strong, with close to $85M available to support our growth plans. This financial strength allows us to complete construction of two, state-of-the-art cultivation and manufacturing facilities in Paris, ON, as well as seek out opportunities for further cultivation expansion. In addition, we will be making strategic investments in R&D, clinical research, marketing and promotion, product development and licensing. Each of these endeavors collectively allows Emblem to maintain its leadership position within the medical side, as well as poises us for a unique and competitive advantage in the adult-use space. Our...

Read More

Corix Bioscience Announces Arrival of OG Group Personnel and Equipment in Adelanto; Installation of Custom-Made Extraction Systems Underway; Operating Team Targets Leadership Role in California Cannabis Industry

IRVINE, Calif., March 20, 2018 (GLOBE NEWSWIRE) — Corix Bioscience Inc. (OTCQB: CXBS), an emerging developer of proprietary cannabis and industrial hemp strains earmarked specifically for use in important healthcare applications, today announced that the relocation of OG Group personnel and equipment from Colorado to California is proceeding smoothly. Corix CEO Michael Ogburn stated, “We are excited that an iconic industry ‘Dream Team’ will be a vital part of Corix Bioscience going forward. I am confident that our joint efforts will result in significant value creation for all of our stakeholders.” Subject to approval of its standard operating plan by the City of Adelanto, OG Group expects to be functioning near full strength in two to three weeks. OG Group president Tim Chan said, “In 2018, the California cannabis industry should generate over $7 billion in revenue. Cultivators and distributors know that we have an unparalleled reputation for excellence with respect to the work we do and the results we achieve. We fully expect OG Group will be the leading cannabis extractor in the state this year.” Anthony Smith, OG Group chief operating officer, commented, “The cannabis industry has not yet seen the unique technology we will utilize at scale in our Adelanto facility. The true extent of what we can do will soon be apparent, and we look forward to a robust demand for our array of value-added...

Read More